IconOVir Bio Announces Formation of Scientific Advisory Board

Founding members bring deep expertise across interconnected fields of oncology research to provide strategic guidance and help advance programs into the clinic SAN DIEGO, CA., April 20, 2021 – IconOVir Bio, Inc. (IconOVir), a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer, today announced […]